• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD
Companion Diagnostics - Streamlining Drug Development and Advancing Personalized Medicine - Product Image

Companion Diagnostics - Streamlining Drug Development and Advancing Personalized Medicine

  • ID: 2596717
  • April 2013
  • Region: Global
  • CBR Pharma Insights

Personalized healthcare encompasses tailored diagnostics, treatment and management of illnesses and diseases. Although the concept has been around for many years, it is only with the advent of companion diagnostics that personalized healthcare has started to gain ground. Companion diagnostics can be used in screening, monitoring, diagnosing and treating patients and can allow for stratification of patients to maximize efficacy and minimize risk

Companion diagnostics can allow for a specific patient population to be identified which will ensure those patients who are most likely to respond are recruited for clinical trials and receive the therapy once the product is launched. Companion diagnostics can help to rationalize treatment decisions, with specifics such as accurate dosing, risks of adverse events and diagnostics being made possible through these tests. Through the use of companion diagnostics, the right treatment can be delivered to the right patient at the right time, delivering greater value and optimizing healthcare resource utilization

Oncology has been the most active arena for companion diagnostics but, as research has advanced and new diagnostics developed, READ MORE >

Note: Product cover images may vary from those shown

1. Executive summary

2. Methodology

3. Personalized medicine and companion diagnostics
- Personalized medicine overview
- What are biomarkers?
- What are companion diagnostics?

4. Advantages of companion diagnostics
- A more targeted patient population
- Focused drug development
- Rationalized treatment decisions
- Pharmacoeconomic advantages

5. Challenges in the development of companion diagnostics
- Logistical challenges
- Strategic business challenges
- Financial risks
- Regulatory challenges

6. Case studies
- Roche - leading the way with companion diagnostics
- Biogen Idec - a diagnostic to mitigate risk
- Xalkori - a sign of things to come?

7. A look to the future
- Companion diagnostics - a prerequisite to approval?
- A world beyond oncology
- Companies leading the way

Appendix

Note: Product cover images may vary from those shown

- Biogen Idec
- Roche
- Xalkori

Note: Product cover images may vary from those shown
Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos